02256.HK
Abbisko Cayman Limited
HKSE · Healthcare · Biotechnology · CN
HKD 6.19
−2.37%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.80x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.51x
- Price / sales
- 33.81x
- Price / cash flow
- -9.83x
Enterprise value
- Enterprise value
- HKD 1.5B
- EV / sales
- 13.30x
- EV / EBITDA
- -2.58x
- EV / EBIT
- -2.50x
- Market cap
- HKD 3.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026